疑似早期卵巢癌微创手术的成本效果研究
该成本效果研究构建决策模型,比较微创手术与开腹手术用于卵巢肿块女性的风险、获益、效果与成本。
要点
- 微创手术平均费用7732美元,低于开腹手术17899美元。
- 微创手术组卵巢破裂64例,开腹手术组53例。
- 微创手术组癌症相关死亡26例,开腹手术组25例。
核心结论
- 对于疑似卵巢肿块的女性,微创手术是一种成本效果的管理策略。
研究设计与样本
- 模型概率、成本和效用值来自已发表文献和行政数据源,并进行了广泛的敏感性分析。
主要发现
- 微创手术平均每例费用7732美元,开腹手术为17899美元。
- 微创手术为优势策略,既成本更低又更有效,且结果在多种敏感性分析中稳健。
关键数值与推荐
- 主要结局指标为增量成本效果比(ICER)。
- 微创手术平均费用7732美元/例,开腹手术17899美元/例。
临床怎么用
- 对于疑似卵巢肿块的女性,可考虑将微创手术作为成本效果更优的手术方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: While there are a number of benefits to minimally invasive surgery (MIS) for women with ovarian cysts, there is an increased risk of ovarian capsule rupture during the procedure, which could potentially seed the abdominal cavity with malignant cells. We developed a decision model to compare the risks, benefits, effectiveness and cost of MIS versus laparotomy in women with ovarian masses. DESIGN: Cost-effectiveness study POPULATION: Hypothetical cohort of 10 000 women with ovarian masses who were undergoing surgical management. METHODS: The initial decision point in the model was performance of surgery via laparotomy or a MIS approach. Model probabilities, costs and utility values were derived from published literature and administrative data sources. Extensive sensitivity analyses were conducted to assess the robustness of the findings. MAIN OUTCOME MEASURES: The primary outcome was the cost-effectiveness of MIS versus laparotomy for women with a pelvic mass measured by incremental cost-effectiveness ratios (ICERs). RESULTS: MIS was the least costly strategy at $7,732 per women on average, compared with $17,899 for laparotomy. In our hypothetical cohort of 10 000 women, there were 64 cases of ovarian rupture in the MIS group and 53 in the laparotomy group, while there were 26 cancer-related deaths in the MIS group and 25 in the laparotomy group. MIS was more effective than laparotomy (188 462 QALYs for MIS versus 187 631 quality adjusted life years [QALYs] for laparotomy). Thus, MIS was a dominant strategy, being both less costly and more effective than laparotomy. These results were robust in a variety of sensitivity analyses. CONCLUSION: MIS constitutes a cost-effective management strategy for women with suspicious ovarian masses. TWEETABLE ABSTRACT: MIS is a cost-effective management strategy for women with suspicious ovarian masses.
引用
- Dioun S, Chen L, Melamed A, et al. Minimally invasive surgery for suspected early-stage ovarian cancer; a cost-effectiveness study. BJOG. 2021. PMID: 34651411. doi:10.1111/1471-0528.16967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。